Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents

• US 20030147958A1
• Filed: 01/29/2002
• Published: 08/07/2003
• Est. Priority Date: 01/29/2002
• Status: Abandoned Application

• Current Assignee: EGEN, Inc. (Imunon, Inc.)
• Original Assignee: EGEN, Inc. (Imunon, Inc.)
• Inventors: Chae, Su Young, Ahn, Cheol-Hee
• Application Number:
  US10/061,003
• Publication Number:
  US 20030147958A1
• Time in Patent Office: Days
• US Class Current: 424/486
• CPC Class Codes: A61K 47/34 Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers A61K47/10 takes precedence
• CPC Class Codes: A61K 47/645 Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
• CPC Class Codes: C12N 15/87 Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Abstract

This patent discloses the synthesis of a multi-block copolymer containing poly(amino acids) (PAA) and a hydrophilic polymer which are degradable under physiological conditions. Control over the degradation rate of the obtained copolymers is achieved by introducing ester, amide or urethane groups as a biodegradable linkage connecting the PAA and the hydrophilic polymer. The biodegradable multi-block copolymers display high transfection efficiency in plasmid delivery with low cytotoxicity.

Claims

1. A biodegradable multi-block copolymer comprising a poly(amino acid) (PAA), and a hydrophilic polymer, wherein the PAA is linked with the hydrophilic polymer by a biodegradable linkage.

2. The biodegradable multi-block copolymer of claim 1 wherein the molar ratio of the PAA to the hydrophilic polymer is within a range of 0.5:

1 to 2;

1.

3. The biodegradable multi-block copolymer of claim 1 wherein the biodegradable linkage is a member selected from the group consisting of esters, amides, urethanes and carbonate.

4. The biodegradable multi-block copolymer of claim 1 wherein the PAA has an average molecular weight of 800 to 200,000 Daltons, the hydrophilic polymer has an average molecular weight of 500 to 20,000 Daltons.

5. The biodegradable multi-block copolymer of claim 1, wherein the hydrophilic polymer is a member selected from the group consisting of polyethylene glycol (PEG), poloxamers, poly(acrylic acid), poly(styrene sulfonate), carboxymethylcellulose, poly(vinyl alcohol), polyvinylpyrrolidone, alpha-substituted poly(oxyalkyl) glycols, poly(oxyalkyl) glycol copolymers and block copolymers, and activated derivatives thereof.

6. The biodegradable multi-block copolymer of claim 5, wherein the hydrophilic polymer is polyethylene glycol (PEG).

7. The biodegradable multi-block copolymer of claim 1, wherein the PAA has a high proportion of positively charged side groups and is a member selected from the group consisting of polylysine, polyarginine, block and graft copolymers thereof and activated derivatives thereof.

8. The biodegradable multi-block copolymer of claim 7, wherein the PAA is polylysine, polyarginine, block and graft copolymers thereof, or activated derivatives thereof.

9. The biodegradable multi-block copolymer of claim 1 further comprising a targeting moiety selected from the group consisting of transferrin, asialoglycoprotein, antibodies, antibody fragments, low density lipoproteins, interleukins, GM-CSF, G-CSF, M-CSF, stem cell factors, erythropoietin, epidermal growth factor (EGF), insulin, asialoorosomucoid, mannose-6-phosphate, mannose, Lewis^X and sialyl Lewis^X, N-acetyllactosamine, galactose, lactose, thrombomodulin, fusogenic agents such as polymixin B and hemaglutinin HA2, lysosomotrophic agents, and nucleus localization signals (NLS).

10. The biodegradable multi-block copolymer of claim 1 further comprising an endosomal escape moiety with buffering capacities between pH 4.0 and 7.2.

11. The biodegradable multi-block copolymer of claim 10 wherein the endosomal escape moiety is a member selected from the group consisting of imidazole derivatives, histidine derivatives, poly(ethylenimine) and poly(L-histidine).

12. A biodegradable multi-block copolymer comprising a poly(amino acid) (PAA) and polyethylene glycol (PEG), wherein the PAA is linked with a PEG by a biodegradable linkage selected from the group consisting of esters, amides, urethanes and carbonate.

13. The biodegradable multi-block copolymer of claim 12, wherein the PAA has an average molecular weight of 800 to 200,000 Daltons, the PEG has an average molecular weight of 500 to 20,000 Daltons, and the molar ratio of the PAA to the PEG is within a range of 0.5:

1 to 2;

1.

14. The biodegradable multi-block copolymer of claim 12, wherein the PAA has a high proportion of positively charged side groups and is a member selected from the group consisting of polylysine, polyarginine, block and graft copolymers thereof and activated derivatives thereof.

15. The biodegradable multi-block copolymer of claim 12 further comprising a targeting moiety selected from the group consisting of transferrin, asialoglycoprotein, antibodies, antibody fragments, low density lipoproteins, interleukins, GM-CSF, G-CSF, M-CSF, stemcell factors, erythropoietin, epidermal growth factor (EGF), insulin, asialoorosomucoid, mannose-6-phosphate, mannose, Lewis^X and sialyl Lewis^X, N-acetyllactosamine, galactose, lactose, and thrombomodulin, fusogenic agents such as polymixin B and hemaglutinin HA2, lysosomotrophic agents, and nucleus localization signals (NLS).

16. The biodegradable multi-block copolymer of claim 12 further comprising an endosomal escape moiety selected from a compound or polymer with buffering capacities between pH 4.0 and 7.2.

17. The biodegradable multi-block copolymer of claim 12 wherein the endosomal escape moiety is a member selected from the group consisting of imidazole derivatives, histidine derivatives, poly(ethylenimine) and poly(L-histidine).

18. A biodegradable multi-block copolymer represented by the formula:

19. The biodegradable multi-block copolymer of claim 18 wherein R′

is a linkage member selected from the group consisting of ester, amide, urethane and carbonate and R represents the residual portion of an amino acid or derivatives thereof which is positively charged under a physiological condition such as lysine, arginine or derivatives thereof.

20. The biodegradable multi-block copolymer of claim 18 wherein R′

is a linkage member selected from the group consisting of ester, amide, and urethane R is a residual portion of a positively charged amino acid selected from the group consisting of lysine, arginine, block and graft cop olymers thereof and activated derivatives thereof.

21. The biodegradable multi-block copolymer of claim 18 further comprising an endosomal escape moiety selected from the group consisting of imidazole derivatives, histidine derivatives, poly(ethylenimine) and poly(L-histidine).

22. A composition for the safe and efficient delivery system of bioactive agents comprising a biodegradable multi-block copolymer capable of forming a stable complex with a bioactive agent, said biodegradable multi-block copolymer comprising a poly(amino acid) (PAA), and a hydrophilic polymer, wherein the PAA is linked with the hydrophilic polymer by a biodegradable linkage.

23. A composition for the safe and efficient delivery system of bioactive agents comprising a biodegradable multi-block copolymer capable of forming a stable complex with a bioactive agent, said biodegradable multi-block copolymer comprising a poly(amino acid) (PAA), and polyethylene glycol (PEG), wherein the PAA is linked with the hydrophilic polymer by a biodegradable linkage selected from the group consisting of ester, amide and urethane.

24. A transfection formulation comprising a biodegradable multi-block copolymer complexed with a selected nucleic acid in the proper charge ratio(positve charge of the copolymer/negative charge of the nucleic acid) that is optimally effective for both in vivo and in vitro transfection, said biodegradable multi-block copolymer comprising a poly(amino acid) (PAA), and a hydrophilic polymer, wherein the PAA has a high proportion of positively charged side groups and is a member selected from the group consisting of polylysine, polyarginine, block and graft copolymers thereof and activated derivatives thereof;

and the PAA is linked with the hydrophilic polymer by a biodegradable linkage.

25. The formulation of claim 24, wherein the hydrophilic polymer is polyethylene glycol (PEG).

26. The formulation of claim 25, wherein the PAA has an average molecular weight of 800 to 200,000 Daltons, the PEG has an average molecular weight of 500 to 20,000 Daltons, and the molar ratio of the PAA to the PEG is within a range of 0.5:

1 to 2;

1.

27. The formulation of claim 24, wherein the weight ratio of DNA to the biodegradable multi-block copolymer is preferably within a range of 1:

0.3 to 1;

16.

28. The formulation of claim 24 further comprising a targeting moiety selected from the group consisting of transferrin, asialoglycoprotein, antibodies, antibody fragments, low density lipoproteins, interleukins, GM-CSF, G-CSF, M-CSF, stemcell factors, erythropoietin, epidermal growth factor (EGF), insulin, asialoorosomucoid, mannose-6-phosphate, mannose, Lewis^X and sialyl Lewis^X, N-acetyllactosamine, galactose, lactose, and thrombomodulin, fusogenic agents such as polymixin B and hemaglutinin HA2, lysosomotrophic agents, and nucleus localization signals (NLS).

29. The formulation of claim 24 further comprising an endosomal escape moiety selected from the group consisting of imidazole derivatives, histidine derivatives, poly(ethylenimine) and poly(L-histidine).

30. A method of transfecting a cell in vitro with biodegradable water soluble multi-block copolymers and a selected plasmid DNA, comprising the steps of:

(a) providing a formulation comprising a biodegradable multi-block copolymer complexed with a selected nucleic acid in the proper charge ratio, said biodegradable multi-block copolymer comprising a poly(amino acid) (PAA), and a hydrophilic polymer, wherein the PAA has a high proportion of positively charged side groups and is a member selected from the group consisting of polylysine, polyarginine, block and graft copolymers thereof and activated derivatives thereof; and

the PAA is linked with the hydrophilic polymer by a biodegradable linkage,

(b) contacting the cell with an effective amount of the formulation such that the cell internalizes the selected nucleic acid; and

(c) culturing the cell with the internalized selected plasmid DNA under conditions favorable for the growth thereof.

31. The method of claim 30, wherein the hydrophilic polymer is a polyethylene glycol (PEG).

32. The method of claim 30, wherein the PAA has an average molecular weight of 800 to 1,000,000 Daltons, the PEG has an average molecular weight of 500 to 20,000 Daltons, and the molar ratio of the PAA to the PEG is within a range of 0.5:

1 to 2;

1.

33. The method of claim 30, wherein the weight ratio of DNA to the biodegradable multi-block copolymer is preferably within a range of 1:

0.3 to 1;

16.

34. The method of claim 30 further comprising a targeting moiety selected from the group consisting of transferrin, asialoglycoprotein, antibodies, antibody fragments, low density lipoproteins, interleukins, GM-CSF, G-CSF, M-CSF, stemcell factors, erythropoietin, epidermal growth factor (EGF), insulin, asialoorosomucoid, mannose-6-phosphate, mannose, Lewis^X and sialyl Lewis^X, N-acetyllactosamine, galactose, lactose, and thrombomodulin, fusogenic agents such as polymixin B and hemaglutinin HA2, lysosomotrophic agents, and nucleus localization signals (NLS).

35. The method of claim 30 further comprising an endosomal escape moiety selected from the group consisting of imidazole derivatives, histidine derivatives, poly(ethylenimine) and poly(L-histidine).